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Research Focuses on
Building New Bone

Fall 2010

Dean’s Message

F

rom the earliest days of
my career in orthopaedic
surgery and chemical
engineering, I have been
fascinated with the prospect of
regrowing bone and connective
tissue to help patients regain
mobility. It is now my privilege
to be leading teams of scientists
not only in my own lab but
throughout the UConn Health
Center who are pursuing
promising research in this area.
This includes Dr. David
Rowe who has devoted most
of his career to the study of
osteogenesis imperfecta and is

Education

now pioneering new approaches
for bone and tissue regeneration
through the use of adult and
embryonic stem cells. These
efforts have received robust
extramural support and have
fostered collaborative efforts with
scientific colleagues throughout
the University of Connecticut –
the top public university in New
England.
Like you, I am confident that
teams on campuses across the
country will continue to make
breakthroughs to improve care
for generations to come. I hope
you will enjoy learning more

about this and some of the
other exciting endeavors at the
UConn School of Medicine.
My best wishes to all as we
begin a new academic year.
Sincerely,

Cato T. Laurencin, M.D., Ph.D.
Vice President for Health Affairs
Dean, UConn School of Medicine
laurencin@uchc.edu

(from left) Megan Almonte,
Travis Townsend, Patrick
Richards, Marja M. Hurley,
M.D., Kierra Odom,
Lamont Freeman, and
Lilliana Garcia.

Diversifying the Health
Professions Pipeline

T

he UConn Health Center’s Health Career Opportunity Programs
(HCOP) open doors to careers in medicine, dental medicine,
biomedical research, and other health professions for students
who are disadvantaged or from populations underrepresented in
such fields.
With funding from public and private sources including the
Aetna Foundation, HCOP director Marja M. Hurley, M.D., oversees
a number of programs collectively known as the Aetna Health
Professions Partnership Initiative (HPPI) pipeline. This year, 23 of
UConn’s 117 medical and dental school graduates were considered
underrepresented – including minority students and those who
are economically or educationally disadvantaged. Fifteen of those
23, more than 65 percent, participated in at least one pipeline
program. “It’s been an increasing trend over really the last 10
years,” Hurley says.
HCOP associate director Granville Wrensford, Ph.D., C.R.A.,
says he’s found the students in the program to be more motivated,
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organized and focused. “And I think it broadens their horizons,
too. They’re talking about a lot more possibilities in terms of what
they would like to do, as opposed to having a narrow focus.”
One pipeline program is the Aetna HPPI Saturday Academy,
which follows students throughout their high school careers.
They meet at UConn’s Hartford campus on Saturdays during the
academic year and full time for six weeks during the summer, with
a focus on advancement in math, science, and language arts, and
standardized testing preparation.
All participants in the Aetna HPPI are mentored by medical,
dental, and graduate students, and faculty at the Health Center.
The pipeline also offers a broad range of programs for middle
school, high school, and college students – from a high schoollevel research apprentice program to a clinical summer research
fellowship program for undergraduate students.
Information on all HCOP enrichment programs is available at
http://hcop.uchc.edu. n
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Research

Can Changes in
the Brain Predict
Disability in
Older Adults?

M

Jim Rusling, Ph.D., left, with graduate students
Ruchika Malhotra and Bhaskara Chikkaveeraiah,
developed a system to better detect interleukin-6.

New Biomarker Technique Could
Provide Early Detection for Oral Cancers

M

odern genetic testing can predict your risk of contracting particular diseases based on
predispositions discovered in your DNA. Jim Rusling, Ph.D., professor of chemistry
at UConn and professor of cell biology at the UConn Health Center, is hoping similar
biotechnology could detect disease even before any symptoms arise.
Rusling and his colleagues have been developing techniques to detect biomarker proteins
– the physiological traits that indicate that a person has a specific disease – for prostate and
oral cancer. Because these biomarkers are often present in the blood in a disease’s early stages,
they can be used for early detection and prevention.
In the journal Analytical Chemistry, Rusling describes a system he and his team developed
to detect with record sensitivity the bloodstream levels of a protein associated with several
types of oral cancer. The protein, called interleukin-6, is normally present in very low levels
in the bloodstream – so low that previous biomarker sensors might not be able to detect it.
This and other biomarkers are signaling molecules, which can instruct cancerous cells to
grow faster. Their levels can increase even before tumors begin to form, enabling early
detection.
Currently, blood samples and antibodies need to be specially prepared and
fed manually into the group’s testing setup. Rusling envisions that in clinics, an
automated tester about the size of a cell phone could be developed to accept a
sample of a person’s blood, analyze the sample, and read out the results. Such
testers could make early detection much easier, he says, which could go a long way
toward saving lives.
“There’s not going to be one cure for cancer, because cancer is thousands of
diseases,” he says. “The best thing for patients is early detection. Biomarker proteins
could become the standard of early detection and treatment monitoring in the future.” n

v

obility is a critical
component of
independence and
quality of life for older persons.
Research by Leslie Wolfson,
M.D., and his team has shown
for the first time that certain
changes in the brain’s white
matter are highly predictive of
the development of disability
in older adults. The results of
the study are published in the
Journal of the American
Geriatrics Society.
Changes involving brain
white matter are seen in many
MRI brain scans of older adults.
“They are so common that
until recently it was assumed
that they don’t matter and
may represent normal aging,”
explains Wolfson, professor
and chair of the Department of
Neurology. “But our research
found that these brain changes
are a good indicator of
problems in older adults such
as difficulty walking, thinking,
and remaining continent.”
Wolfson believes that
interventions such as aggressive
treatment of elevated blood
pressure may help prevent or
slow these declines,
allowing older
adults to remain
independent,
vigorous,
and healthy
longer. n
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Cell-Based Therapy
Focuses on Building New Bone

D

avid Rowe, M.D., is confident that medical science will one
day enable patients to regrow bone and other tissues lost
to disease, trauma, or aging. Rowe, director of the UConn
School of Dental Medicine’s Center for Regenerative Medicine and
Skeletal Development, is quick to note that this breakthrough,
like others over the centuries, will be achieved only through
rigorous, persistent research.
“It’s a very difficult challenge,” Rowe says. “A lot of work
needs to be done before this becomes a reality. But we have the
people, the tools, the resources, and the commitment to move
the research forward.”

UConn School of Medicine

The research Rowe and his colleagues are engaged in
focuses on how to use embryonic and adult stem cells to
regenerate bone and other tissues in the body. The team has
received funding for its work from the Connecticut Stem Cell
Research Program, the National Institutes of Health, and the
Department of Defense.
Rowe himself was recently honored as the recipient of
the 2010 UConn Health Center Board of Directors Faculty
Recognition Award. The award recognizes Rowe’s outstanding
contributions to research, teaching, and mentoring.

w

“This is a huge area,” says Rowe. “Because of the war and the
horrific injuries that in the past would have killed soldiers, there
is enormous interest in coming up with strategies to try to salvage
bone that has sustained such devastating injuries.”

A Multidisciplinary Approach

R

owe points out that the Health Center has been a leader
in connective tissue research for nearly 40 years, having
recruited people with expertise in this field when the Schools
of Medicine and Dental Medicine were founded.
“The Health Center – and UConn in general – has been a
powerhouse nationally and internationally in this area,” he says.
With such a high concentration of expertise available within the
institution, Rowe and his colleagues in the Center for Regenerative
Medicine and Skeletal Development have made it a point to
cultivate a multidisciplinary approach. They work with tissue
engineering specialists led by Cato T. Laurencin, M.D., Ph.D.,
dean of the School of Medicine, and collaborate with the New
England Musculoskeletal Institute’s Department of Orthopaedic
Surgery, directed by Jay R. Lieberman, M.D. They also work
with experts at the University’s Storrs campus, including tissue
engineers and specialists in materials science and computer
science. “We see ourselves as having a central, coordinating role,”
Rowe says. “We’ve built the infrastructure and can do the testing
and evaluation of various ideas.”

David Rowe, M.D. reviews research
data with Xiaonan Xin. Li Chen works
in the background.

“It’s a very difficult challenge,” Rowe
says. “A lot of work needs to be done
before this becomes a reality. But we
have the people, the tools, the resources,
and the commitment to move the
research forward.”
The Next Breakthrough

R

Treating Disease and Injury

owe sees his research on stem cells and regeneration as the
next major step in the centuries-old evolution of medicine.
Milestones in that evolution have included Hippocrates’
discovery of anatomy; understanding of infectious disease and
immunization; innovations in anesthesia and sterile technique, which
gave rise to modern surgery; development of antibiotics and the
pharmaceutical industry; and breakthroughs in molecular biology
and genetics, which brought about new diagnostic tools and drugs.
The next major breakthrough, Rowe predicts, will be cellbased therapy, not only for use in bone regeneration, but also in
neuroscience, endocrinology, and other fields.
“The breakthrough would be to take a patient’s own cells, put
them through a process to engineer them to be any cell in the
body you want them to be, and put them back into the body
and have them be a match,” Rowe says. “It’s the ultimate in
personalized, cell-based therapy. This is where medicine has to
go, and we’re at the dawn of that revolution.” n

O

steogenesis imperfecta is Rowe’s main research interest.
Commonly known as brittle bone disease, OI is a genetic
disease that causes bones to be extremely fragile and to
fracture easily. He and his colleagues are working to discover
how to treat the disease by correcting the genetic defect in the
patient’s own cells.
“We’re looking for ways to identify the progenitor stem cells
that exist in the body, remove them, engineer them, and put
them back in so they’ll function normally,” says Rowe.
An offshoot of this research deals with treating traumatic
injuries, especially those sustained by members of the armed
forces serving in war zones. The team has funding from the
Department of Defense to develop strategies for salvaging limbs
that would otherwise have to be amputated. The DOD is a
major supporter of such research nationwide.

x
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Gifts

A Scholarship Student Becomes a
Scholar, Then a Scholarship Donor

to the UConn Honors Program. The gift will provide
much-needed support to the existing John and Valerie
Rowe Health Professions Scholars Program, which
encourages academically gifted students from
ack Rowe, M.D., has had many titles in his
underrepresented groups and low-income families
life: professor at Harvard and Columbia, CEO
to enter the health professions. The program is
and chairman of Aetna, CEO of Mount Sinai
administered by the University’s Honors Program in
Medical Center and School of Medicine in New
partnership with the UConn Health Center.
York City, chair of the board of the University of
“For me and my wife, our particular interest was in
Connecticut, and one last title that actually came first:
trying to give disadvantaged students who are academically
Jack Rowe, M.D.
scholarship student.
talented the opportunity to reach their full potential,”
“I only had the benefit of higher education because I had full
he says. “The health professions are desperately in need of
academic scholarships to college,” he says. “My family otherwise
more talented minority physicians and nurses and dentists
would not have been able to send me to school.”
and lab technicians, and that’s been a consistent observation
College, then, made just about everything else in his
throughout my career. That’s why we did this.”
life possible. From Canisius College in Buffalo, N.Y., to the
“Rowe Scholars have been admitted to medical, dental,
University of Rochester School of Medicine and Dentistry, to
and nursing schools, worked on honors theses, and served as
Harvard Medical School and numerous high-profile positions,
campus leaders,” says Lynne Goodstein, director of the Honors
Rowe has had a lifelong involvement with education.
Program. “The Rowes’ gift is a statement of their confidence in
He and his wife, Valerie Rowe, Ph.D., a former professor at
the Honors Program to provide life-changing opportunities to
Fordham University, recently took their commitment one step
deserving students.” n
further with a $2 million pledge through the UConn Foundation
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White Coat Gala Benefits
Clinician-Scientists

C

linician-scientists at the Health Center are at the forefront
of medicine, integrating clinical care, research, and
basic science to bring discoveries from the bench to the
bedside. This past spring, nearly 500 people attended the
inaugural White Coat Gala, raising more than $450,000 to
benefit clinician-scientists across the Health Center.
The honoree of the evening was Board of Trustees
Distinguished Professor of Medicine Lawrence G. Raisz, M.D.
Raisz has earned international prominence and numerous
prestigious awards for his groundbreaking work in the
management of osteoporosis and metabolic bone disease. At
the Health Center, he headed the Division of Endocrinology
and Metabolism until 1997 and served as the first program
director of the Lowell P. Weicker, Jr. General Clinical Research
Center. He has been the director of the UConn Center for
Osteoporosis since its inception in 1990 and is associate
director of the New England Musculoskeletal Institute.
Title sponsorship for the gala was generously provided by
Aetna and Carole and Ray Neag, longtime supporters of the
Health Center and the University. n

Nearly 500 people attended the University of Connecticut Health Center’s
inaugural White Coat Gala. The event raised more than $450,000 for Health
Center clinician-scientists.
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Honors

Drs. Anne Kenny and Anna DongariBagtzoglou Accepted to Prestigious
Leadership Program

Christopher Hughes Awarded
Prestigious Paul Farmer Global
Surgery Research Fellowship

T

he Hedwig van Ameringen
Executive Leadership in
Academic Medicine® (ELAM)
Program for Women at Drexel
University College of Medicine has
been an important and prestigious
source of leadership training for
women nationally and at the
Health Center.
Recently accepted into the next
class of this highly competitive
program are Anne Kenny, M.D.,
associate professor in the Department Anne Kenny, M.D.
of Medicine and the Center on Aging,
and Anna Dongari-Bagtzoglou,
D.D.S., M.S., Ph.D., associate
professor in the Department of Oral
Health Sciences and chair of the
School of Dental Medicine’s Division
of Periodontology.
Kenny is widely published; her
clinical interests include interventions
that decrease risk for falls, fractures,
and frailty in older men and women,
such as testosterone and vitamin D
Anna Dongari-Bagtzoglou, D.D.S., M.S., Ph.D.
supplementation. In recent years, she
has played a pivotal role in the development of the master’s degree
in clinical and translational research. Dongari-Bagtzoglou was
recently appointed to the National Advisory Dental and Craniofacial
Research Council. Her research interests include the pathogenesis
of oral opportunistic infections in the immunocompromised host
and oral infection-induced inflammation. n

Christopher Hughes, M.D. (far left), pictured with other members of his surgical team
working at a Bolivian hospital last year.

C

hristopher Hughes, M.D., second-year UConn general
surgery resident, has been named the Paul Farmer
Global Surgery Research Fellow at the Children’s
Hospital in Boston.
Hughes, who has participated in several international
surgical and medical trips to Belize, Bolivia, Honduras, India,
and Ecuador, will spend the next two years researching and
performing surgical care in Haiti and Africa.
“We’re kind of at the convergence of a lot of different forces
involving international surgery at this point,” explains Hughes.
“The documented need for surgery in resource-poor settings
around the world is escalating, and people are actually looking
into ways of capturing what those needs are for poor people and
poor countries around the world.”
In the future, Hughes believes more surgical
epidemiologists will look for surgery to fit in a broader context
of the overall health care system. “The success of medical
missions is often judged by how many surgeries the doctors
performed,” explains Hughes. “But when we leave and
dump the patients’ complications and follow-up care on the
community doctor who is already overwhelmed, does that
benefit the community as a whole?” n

Fast Fact

$101,908,000 received

for biomedical research at the UConn
Health Center last fiscal year.
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Health Care Hero in Haiti

W

ithin days of the earthquake that
devastated Haiti, Robert Fuller, M.D.,
head of emergency medicine, was among the
first physicians to arrive with the International
Medical Corps to treat nearly 1,500 people for
wounds, crush injuries, trauma, and shock.
Fuller’s work in Port-au-Prince was recognized
with a 2010 Health Care Hero Award from the
Connecticut Hospital Association.
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